American Health Research

Executive Summary

American Health Research (AHR) is a privately held, independent clinical research site company headquartered in Charlotte, North Carolina. Founded in 2012 by Dr. Selwyn Spangenthal, AHR specializes in conducting clinical trials for pharmaceutical sponsors, with a strong focus on patient safety, data integrity, and high-quality volunteer experiences. The company operates two sites: its primary location in Charlotte and a secondary site, Clinical Research of Rock Hill, in South Carolina, expanding its reach into northern South Carolina. AHR’s expertise spans digital health and diagnostics, positioning it to support a wide range of Phase I–IV studies. Despite being a small, private entity with no disclosed funding rounds or valuation, AHR’s long-standing presence since 2012 and physician-led leadership lend credibility in the competitive clinical research site market. As an independent site, AHR differentiates itself through personalized patient recruitment and retention strategies, which are critical to trial timelines. The company’s focus on data integrity and safety aligns with sponsor demands for reliable outcomes. However, its limited scale relative to larger site networks may constrain growth potential. The clinical research site industry benefits from steady demand as pharmaceutical companies outsource trial execution. AHR’s established footprint in the Carolinas provides a regional advantage, but visibility beyond its local market remains low. Overall, American Health Research represents a niche player with stable operations, though its lack of public catalysts and small size temper upside expectations.

Upcoming Catalysts (preview)

• Q3 2026Award of new clinical trial contracts from top-20 pharma sponsors50% success